Luye Pharma Group (HKG:2186) entered into agreements with a subscriber for the conditional issuance of bonds worth $150 million, according to a Wednesday filing with the Hong Kong bourse.
Two tranches of $100 million and $50 million convertible bonds will be issued. Both tranches have a 5.85% interest rate and will mature in 2025. The proceeds will be used to refinance debt and support research and development.
These bonds can be converted into shares at HK$3.67 per share. The amount represents about 8.44% of the current issued share capital. The transaction remains subject to conditions.
The share prices of the pharmaceutical were down by almost 2% in recent trading.
Price (HKD): $3.01, Change: $-0.050, Percent Change: -1.63%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。